Pharming Group N.V.

PHAR

NYSE EURONEXT - EURONEXT AMSTERDAMHealth Care

Income Statement

Total Revenue$319.79M

Gross Profit$281.79M

Operating Income$-9.54M

EBITDA$7.69M

EBIT$-9.5M

Pre-tax Income$12.85M

Net Income$-13.01M

Cash Equivalent$57.93M

Total Debt$142.79M

Book Value$238.34M

Book Value Per Share0.35

Return on Equity (ROE)-5.36%

Return on Assets (ROA)-2.96%

Return on Invested Capital (ROI)-3.55%

Net Profit Margin-3.98%

Current Ratio3.77

Quick Ratio2.95

Long-Term Debt / Equity0.35